Literature DB >> 18299973

Short QT syndrome review.

Nathan E Van Houzen1, Alawi A Alsheikh-Ali, Ann C Garlitski, Munther K Homoud, Jonathan Weinstock, Mark S Link, N A Mark Estes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18299973     DOI： 10.1007/s10840-008-9201-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  24 in total

1.  Idiopathic short QT interval: a new clinical syndrome?

Authors:  I Gussak; P Brugada; J Brugada; R S Wright; S L Kopecky; B R Chaitman; P Bjerregaard
Journal:  Cardiology       Date:  2000       Impact factor: 1.869

2.  Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children.

Authors:  Giuseppe Boriani; Mauro Biffi; Cinzia Valzania; Gabriele Bronzetti; Cristian Martignani
Journal:  Eur Heart J       Date:  2006-09-04       Impact factor: 29.983

Review 3.  Short QT syndrome.

Authors:  Ramon Brugada; Kui Hong; Jonathan M Cordeiro; Robert Dumaine
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

4.  Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.

Authors:  Christian Wolpert; Rainer Schimpf; Carla Giustetto; Charles Antzelevitch; Jonathan Cordeiro; Robert Dumaine; Ramon Brugada; Kui Hong; Urs Bauersfeld; Fiorenzo Gaita; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2005-01

5.  Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome.

Authors:  Fabrice Extramiana; Charles Antzelevitch
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

6.  Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.

Authors:  Mark J McPate; Rona S Duncan; Harry J Witchel; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2006-07-12       Impact factor: 5.000

7.  Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.

Authors:  J M Cordeiro; R Brugada; Y S Wu; K Hong; R Dumaine
Journal:  Cardiovasc Res       Date:  2005-03-28       Impact factor: 10.787

8.  Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.

Authors:  Rainer Schimpf; Christian Wolpert; Francesca Bianchi; Carla Giustetto; Florenzo Gaita; Urs Bauersfeld; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2003-12

9.  Sudden death associated with short-QT syndrome linked to mutations in HERG.

Authors:  Ramon Brugada; Kui Hong; Robert Dumaine; Jonathan Cordeiro; Fiorenzo Gaita; Martin Borggrefe; Teresa M Menendez; Josep Brugada; Guido D Pollevick; Christian Wolpert; Elena Burashnikov; Kiyotaka Matsuo; Yue Sheng Wu; Alejandra Guerchicoff; Francesca Bianchi; Carla Giustetto; Rainer Schimpf; Pedro Brugada; Charles Antzelevitch
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

10.  Mutation in the KCNQ1 gene leading to the short QT-interval syndrome.

Authors:  Chloé Bellocq; Antoni C G van Ginneken; Connie R Bezzina; Mariel Alders; Denis Escande; Marcel M A M Mannens; Isabelle Baró; Arthur A M Wilde
Journal:  Circulation       Date:  2004-05-25       Impact factor: 29.690
View more
  3 in total

1.  A truly new view from the summit: from translational science to outcomes research in clinical arrhythmology.

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2010-01       Impact factor: 1.900

Review 2.  The short QT syndrome.

Authors:  Brian Cross; Munther Homoud; Mark Link; Caroline Foote; Ann C Garlitski; Jonathan Weinstock; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2011-04-14       Impact factor: 1.900

3.  Association of MEF2A gene polymorphisms with coronary artery disease.

Authors:  Ali Mohammad Foroughmand; Zahra Shahbazi; Hamid Galehdari; Mahdi Purmahdi Borujeni; Parvane Dinarvand; Khadije Golabgirkhademi
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.